Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

about

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

Item

http://www.wikidata.org/entity/Q40460665

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

@en

type

Item

label

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

@en

prefLabel

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

@en

P1476

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice

@en

P2093

Adil Huseynov

http://www.w3.org/2001/XMLSchema#string

Arif Ibiş

http://www.w3.org/2001/XMLSchema#string

Evren Suer

http://www.w3.org/2001/XMLSchema#string

Mehmet Ilker Gokce

http://www.w3.org/2001/XMLSchema#string

Semih Tangal

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunoediting from immune surveillance to immune escape

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients.

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy

Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

Biomarkers in prostate cancer surveillance and screening: past, present, and future.

Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.

The lymphocyte-monocyte ratio in clinical practice.

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.3630

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nurullah Hamidi

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217864

http://www.w3.org/2001/XMLSchema#string

P932

4839998

http://www.w3.org/2001/XMLSchema#string